Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Filings indexed 7,016 across all filing types
Latest filing 2025-12-16 Regulatory Filings
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
EXDENSUR (DEPEMOKIMAB) UK MHRA APPROVAL
Regulatory Filings
2025-12-16 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-12-16 English
Exdensur (depemokimab) UK MHRA approval
Regulatory Filings Classification · 100% confidence The document is a press release from GSK plc announcing the regulatory approval of a new drug, Exdensur (depemokimab), by the UK's MHRA. It details the clinical trial results (SWIFT and ANCHOR), the drug's indications, and future regulatory expectations. This is a standard corporate regulatory announcement distributed via RNS (Regulatory News Service). It does not fit into specific categories like 10-K, AGM-R, or DIRS, and is not a report publication announcement (RPA) as it is the primary announcement of the news itself. Therefore, it falls under the RNS (Regulatory Filings) category.
2025-12-16 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from GSK plc regarding the purchase of its own shares (share buyback). It explicitly states 'Transaction in own shares' in the header and provides detailed trade data, including dates, prices, and trading venues. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-12-16 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Director's Dealing
2025-12-15 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-12-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.